Dyne Therapeutics Announces Upcoming Presentations Across Neuromuscular Pipeline at 2026 MDA Clinical & Scientific Conference
(NASDAQ:DYN), – Late-breaking poster to feature new positive cardiopulmonary function results from the DELIVER trial of z-rostudirsen in DMD – – Oral presentation on Phase 3 trial design for z-basivarsen in DM1 – – Five total presentations across three neuromuscular diseases demonstrate strength of Dyne's pipeline based on clinically-validated FORCE(TM) platform – WALTHAM, Mass., Feb. […]